
Richard Epstein on Property Rights and Drug Patents
EconTalk
00:00
Who benefits from stronger FDA rules?
They examine the 'bootleggers and Baptists' view and whether big pharma benefits from costly regulation.
Play episode from 52:40
Transcript

They examine the 'bootleggers and Baptists' view and whether big pharma benefits from costly regulation.